Telehealth provider Teladoc last week accused Amwell of infringing on its patents and demanded that its rival stop offering the products in question — setting the stage for a potential legal dispute between the two most prominent companies in telemedicine.
In a Sept. 14 letter to Amwell obtained by STAT, Teladoc’s intellectual property attorneys pointed to Amwell’s digital scope and stethoscope, as well as several of its telemedicine carts — wheeled devices equipped with cameras and screens that telehealth providers use to connect remote clinicians with patients on-site. The letter, addressed to Amwell’s CEOs, Ido and Roy Schoenberg, alleges that one or more of these products “directly and indirectly infringe” patents that Teladoc took ownership of earlier this year through an acquisition of telemedicine startup InTouch in a deal announced in January.
About the Author Reprints
